Designed to help providers characterize and differentiate breast masses in real-time, Imagio combines laser optics and grayscale ultrasound to provide fused functional and anatomical breast imaging, according to the vendor. These optoacoustic images provide a blood map in and around breast masses, while the ultrasound technology yields a traditional anatomic image, Seno said. The company believes that Imagio could help to reduce the number of unnecessary diagnostic breast biopsies.

Imagio also comes with SenoGram, an artificial intelligence (AI)-based decision-support tool for aiding radiologists in interpreting the new images and helping them in transitioning from ultrasound alone to optoacoustic ultrasound imaging, the firm said.